Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation | |
---|---|---|
drug3320 | The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: Wiki | 0.58 |
drug2341 | PLACEBO GROUP Wiki | 0.58 |
drug608 | COVID-19 barrier box Wiki | 0.58 |
Name (Synonyms) | Correlation | |
---|---|---|
D009080 | Mucocutaneous Lymph Node Syndrome NIH | 0.58 |
D001997 | Bronchopulmonary Dysplasia NIH | 0.58 |
D008595 | Menorrhagia NIH | 0.58 |
Name (Synonyms) | Correlation | |
---|---|---|
D006929 | Hyperaldosteronism NIH | 0.58 |
D013226 | Status Epilepticus NIH | 0.58 |
D014552 | Urinary Tract Infections NIH | 0.58 |
D002543 | Cerebral Hemorrhage NIH | 0.58 |
D054559 | Hyperphosphatemia NIH | 0.58 |
D004314 | Down Syndrome NIH | 0.58 |
D013345 | Subarachnoid Hemorrhage NIH | 0.58 |
D000309 | Adrenal Insufficiency NIH | 0.58 |
D007008 | Hypokalemia NIH | 0.58 |
D000070642 | Brain Injuries, Traumatic NIH | 0.41 |
D001289 | Attention Deficit Disorder with Hyperactivity NIH | 0.33 |
D001930 | Brain Injuries, NIH | 0.26 |
D020521 | Stroke NIH | 0.15 |
D020141 | Hemostatic Disorders NIH | 0.15 |
D001778 | Blood Coagulation Disorders NIH | 0.15 |
D006973 | Hypertension NIH | 0.14 |
D004194 | Disease NIH | 0.12 |
D014947 | Wounds and Injuries NIH | 0.11 |
D013577 | Syndrome NIH | 0.06 |
D003141 | Communicable Diseases NIH | 0.04 |
D007239 | Infection NIH | 0.03 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.02 |
D018352 | Coronavirus Infections NIH | 0.02 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0002905 | Hyperphosphatemia HPO | 0.58 |
HP:0002900 | Hypokalemia HPO | 0.58 |
HP:0002133 | Status epilepticus HPO | 0.58 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0000846 | Adrenal insufficiency HPO | 0.58 |
HP:0002138 | Subarachnoid hemorrhage HPO | 0.58 |
HP:0000132 | Menorrhagia HPO | 0.58 |
HP:0001342 | Cerebral hemorrhage HPO | 0.58 |
HP:0000859 | Hyperaldosteronism HPO | 0.58 |
HP:0007018 | Attention deficit hyperactivity disorder HPO | 0.33 |
HP:0001297 | Stroke HPO | 0.15 |
HP:0001928 | Abnormality of coagulation HPO | 0.15 |
HP:0000822 | Hypertension HPO | 0.14 |
Navigate: Correlations HPO
There are 3 clinical trials
The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.
The main objectives are: - To establish the prevalence of major bleeding in patients treated with higher than recommended thromboprophylaxis doses. - To identify variables associated to higher risk of bleeding.
Description: Study endpoints are clinically recognized (and objectively confirmed) major and minor bleeding complications, and death.
Measure: Bleeding events and complications Time: 30 daysA prospective cohort minimal risk study to determine the impact of the COVID-19 crisis on outcomes of neurologically injured ICU patients.
Description: Care treatment such as ventilator use, intubation, and/or tracheostomy
Measure: Limitations of patient care- Frequency of care not being provided Time: During In-hospital course, up to 1 monthAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports